CMN-005 is under clinical development by CoImmune and currently in Phase II for Splenic Marginal Zone B-Cell Lymphoma. According to GlobalData, Phase II drugs for Splenic Marginal Zone B-Cell Lymphoma ...
At the hospital, he was informed that he needed surgery, and was admitted for “intra-abdominal hemorrhage associated with splenic artery aneurysm rupture” and “cardiac arrest,” according ...